
Caris AI Study Links Treatment Selection to Longer Survival in Pancreatic Cancer
A Caris study found AI-guided treatment selection was associated with longer survival in pancreatic cancer patients using molecular data.
PharmaCompany

A study by Caris Life Sciences demonstrated that AI-guided treatment selection, based on molecular data, is linked to longer survival rates in patients with pancreatic cancer.
+0 in the last 30 days
Latest: Aug 31, 2026
Latest tracker entry
16.0 median overall survival (months)
Built on Whole Exome Sequencing, Whole Transcriptome Sequencing




MachineCon USA · from AIM Media House
An invitation-led day for the CIOs, CDOs and Chief AI Officers who own enterprise AI strategy.



